Invention Grant
- Patent Title: Cationic lipid
-
Application No.: US15502063Application Date: 2015-08-06
-
Publication No.: US10252974B2Publication Date: 2019-04-09
- Inventor: Yasutaka Hoashi
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent David G. Conlin; Joohee Lee
- Priority: JP2014-161718 20140807
- International Application: PCT/JP2015/072344 WO 20150806
- International Announcement: WO2016/021683 WO 20160211
- Main IPC: C07C69/00
- IPC: C07C69/00 ; C07C229/00 ; A61K31/00 ; A61K47/00 ; C11C3/00 ; C07C69/34 ; A61K47/18 ; A61K48/00 ; A61K31/7105 ; A61K31/713 ; C07C229/12 ; A61K9/08 ; C12N15/113 ; A61K9/107 ; A61K9/127
Abstract:
The present invention provides a technology which enables introduction of an active ingredient (e.g. nucleic acids) into various cells with a high efficiency, and compounds used therefor. The present invention provides a compound represented by the formula: [wherein, each symbol is as defined in the present description] or a salt thereof.
Public/Granted literature
- US20170197903A1 CATIONIC LIPID Public/Granted day:2017-07-13
Information query
